Clinical Experience with Daptomycin for the Treatment of Gram-positive Infections in Children and Adolescents

BACKGROUND: This subgroup analysis of the European Cubicin Outcomes Registry Experience evaluated the safety and effectiveness of daptomycin in children and adolescent patients (<18 years). METHODS: Clinical outcomes at the end of therapy were assessed as success (cured or improved), failure or n...

Descripción completa

Detalles Bibliográficos
Autores principales: Syriopoulou, Vassiliki, Dailiana, Zoe, Dmitriy, Nisichenko, Utili, Riccardo, Pathan, Rashidkhan, Hamed, Kamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Williams & Wilkins 2016
Materias:
Antimicrobial Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830747/
https://www.ncbi.nlm.nih.gov/pubmed/26849158
http://dx.doi.org/10.1097/INF.0000000000001076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830747/
https://www.ncbi.nlm.nih.gov/pubmed/26849158
http://dx.doi.org/10.1097/INF.0000000000001076

Ejemplares similares